Published May 5, 2020
| Version v1
Patent
Open
Recombinant antibodies that recognize the C-terminal domains of Ebola virus nucleoprotein
Creators
- 1. University of Virginia
- 2. University of Chicago
Contributors
Patent applicants:
Description
This disclosure is directed to compositions and methods for utilizing the boundaries of the C-terminal domains of Nucleoprotein from Zaire Ebola virus as highly stable recombinant protein antigens to generate antibodies for diagnosis and treatment of Ebola virus infection.
Files
US10640549.pdf
Files
(2.8 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:eafdc8a3a687d28e0be31ca614711372
|
2.8 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 10640549 B2
- Patent application number
- US 201515518417 A
- Other
- oai:uchicago.tind.io:6947
Dates
- Patent filed
-
2015-10-16